The use of optic nerve sheath diameter to assess the effect of succinylcholine on intracranial pressure in cesarean section surgery: a prospective controlled clinical study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511663348568

Enrollment

Registered

2025-11-13

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Rocuronium injection

Succinylcholine injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: • Age 18-45 years • Mallampati I and II • American society of anesthesiologists (ASA) physical state II • CS needs GA • mother with Singleton fetus • mother with Full term baby

Exclusion criteria

Exclusion criteria: • Patient refusal to participate • History of contraindication for succinylcholine or rocuronium. • Urgent CS • Fetal anomalies • Sever cardiac diseases • Sever anticipated bleeding in CS • Hepatic or renal diseases • Hypertensive diseases of pregnancy

Design outcomes

Primary

Measure	Time frame
the measurement of optic nerve sheath diameter in mm after intubation in patients scheduled for CS surgery	—

Secondary

Measure	Time frame
any side effects for succinylcholine	—

Countries

Egypt

Contacts

Public ContactAli Hassan Goda

residant doctor at Anesthesia Intesive Care Pain Management Assiut university

Ali.16266239@med.aun.edu.eg+201554546034

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026